186 related articles for article (PubMed ID: 30849081)
1. Long-term visual acuity in patients with optic pathway glioma treated during childhood with up-front BB-SFOP chemotherapy-Analysis of a French pediatric historical cohort.
Rakotonjanahary J; Gravier N; Lambron J; De Carli E; Toulgoat F; Delion M; Pellier I; Rialland X
PLoS One; 2019; 14(3):e0212107. PubMed ID: 30849081
[TBL] [Abstract][Full Text] [Related]
2. Mortality in Children with Optic Pathway Glioma Treated with Up-Front BB-SFOP Chemotherapy.
Rakotonjanahary J; De Carli E; Delion M; Kalifa C; Grill J; Doz F; Leblond P; Bertozzi AI; Rialland X;
PLoS One; 2015; 10(6):e0127676. PubMed ID: 26098902
[TBL] [Abstract][Full Text] [Related]
3. Long-term visual outcome after chemotherapy for optic pathway glioma in children: Site and age are strongly predictive.
Dodgshun AJ; Elder JE; Hansford JR; Sullivan MJ
Cancer; 2015 Dec; 121(23):4190-6. PubMed ID: 26280460
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal measures of visual function, tumor volume, and prediction of visual outcomes after treatment of optic pathway gliomas.
Kelly JP; Leary S; Khanna P; Weiss AH
Ophthalmology; 2012 Jun; 119(6):1231-7. PubMed ID: 22364864
[TBL] [Abstract][Full Text] [Related]
5. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program.
Dalla Via P; Opocher E; Pinello ML; Calderone M; Viscardi E; Clementi M; Battistella PA; Laverda AM; Da Dalt L; Perilongo G
Neuro Oncol; 2007 Oct; 9(4):430-7. PubMed ID: 17704361
[TBL] [Abstract][Full Text] [Related]
6. Visual acuity of children treated with chemotherapy for optic pathway gliomas.
Kalin-Hajdu E; Décarie JC; Marzouki M; Carret AS; Ospina LH
Pediatr Blood Cancer; 2014 Feb; 61(2):223-7. PubMed ID: 23956233
[TBL] [Abstract][Full Text] [Related]
7. Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis.
Fisher MJ; Loguidice M; Gutmann DH; Listernick R; Ferner RE; Ullrich NJ; Packer RJ; Tabori U; Hoffman RO; Ardern-Holmes SL; Hummel TR; Hargrave DR; Bouffet E; Charrow J; Bilaniuk LT; Balcer LJ; Liu GT
Neuro Oncol; 2012 Jun; 14(6):790-7. PubMed ID: 22474213
[TBL] [Abstract][Full Text] [Related]
8. Optic pathway glioma: long-term visual outcome in children without neurofibromatosis type-1.
Campagna M; Opocher E; Viscardi E; Calderone M; Severino SM; Cermakova I; Perilongo G
Pediatr Blood Cancer; 2010 Dec; 55(6):1083-8. PubMed ID: 20979170
[TBL] [Abstract][Full Text] [Related]
9. Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1.
Wan MJ; Ullrich NJ; Manley PE; Kieran MW; Goumnerova LC; Heidary G
J Neurooncol; 2016 Aug; 129(1):173-8. PubMed ID: 27311725
[TBL] [Abstract][Full Text] [Related]
10. Neurofibromatosis Type 1-Associated Optic Pathway Glioma in Children: A Follow-Up of 10 Years or More.
Kinori M; Armarnik S; Listernick R; Charrow J; Zeid JL
Am J Ophthalmol; 2021 Jan; 221():91-96. PubMed ID: 32283094
[TBL] [Abstract][Full Text] [Related]
11. Fractional anisotropy of the optic radiations is associated with visual acuity loss in optic pathway gliomas of neurofibromatosis type 1.
de Blank PM; Berman JI; Liu GT; Roberts TP; Fisher MJ
Neuro Oncol; 2013 Aug; 15(8):1088-95. PubMed ID: 23658320
[TBL] [Abstract][Full Text] [Related]
12. NEUROFIBROMATOSIS TYPE 1 AND OPTIC PATHWAY GLIOMA.
Siwá A; Autrata R; Vejmělková K; Pavelka Z; Zitterbart K
Cesk Slov Oftalmol; 2019; 75(4):200-208. PubMed ID: 32397722
[TBL] [Abstract][Full Text] [Related]
13. Does chemotherapy affect the visual outcome in children with optic pathway glioma? A systematic review of the evidence.
Moreno L; Bautista F; Ashley S; Duncan C; Zacharoulis S
Eur J Cancer; 2010 Aug; 46(12):2253-9. PubMed ID: 20400294
[TBL] [Abstract][Full Text] [Related]
14. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
Gnekow AK; Kortmann RD; Pietsch T; Emser A
Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
[TBL] [Abstract][Full Text] [Related]
15. Long-term visual outcome following chemoreduction for retinoblastoma.
Demirci H; Shields CL; Meadows AT; Shields JA
Arch Ophthalmol; 2005 Nov; 123(11):1525-30. PubMed ID: 16286614
[TBL] [Abstract][Full Text] [Related]
16. Long-term visual acuity outcomes after radiation therapy for sporadic optic pathway glioma.
Acharya S; Quesada S; Coca K; Richardson C; Hoehn ME; Chiang J; Qaddoumi I; Boop FA; Gajjar A; Merchant TE
J Neurooncol; 2019 Sep; 144(3):603-610. PubMed ID: 31414376
[TBL] [Abstract][Full Text] [Related]
17. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC
J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
[TBL] [Abstract][Full Text] [Related]
18. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
Friedrich RE; Nuding MA
Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519
[TBL] [Abstract][Full Text] [Related]
19. Predictors of long-term visual outcome after chemoreduction for management of intraocular retinoblastoma.
Narang S; Mashayekhi A; Rudich D; Shields CL
Clin Exp Ophthalmol; 2012; 40(7):736-42. PubMed ID: 22300311
[TBL] [Abstract][Full Text] [Related]
20. Visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) Low-Grade Glioma 2004 trial UK cohort.
Falzon K; Drimtzias E; Picton S; Simmons I
Br J Ophthalmol; 2018 Oct; 102(10):1367-1371. PubMed ID: 29343527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
